70 related articles for article (PubMed ID: 23412975)
21. Vitamin D receptor genetic variants are associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer.
Xiong L; Cheng J; Gao J; Wang J; Liu X; Wang L
Clin Lung Cancer; 2013 Jul; 14(4):433-9. PubMed ID: 23522953
[TBL] [Abstract][Full Text] [Related]
22. Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients.
Peng Y; Li Z; Zhang S; Xiong Y; Cun Y; Qian C; Li M; Ren T; Xia L; Cheng Y; Wang D
Int J Cancer; 2014 Dec; 135(11):2687-96. PubMed ID: 24729390
[TBL] [Abstract][Full Text] [Related]
23. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
Qian CY; Zheng Y; Wang Y; Chen J; Liu JY; Zhou HH; Yin JY; Liu ZQ
Chin J Cancer; 2016 Sep; 35(1):85. PubMed ID: 27590272
[TBL] [Abstract][Full Text] [Related]
24. Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.
Gu S; Wu Q; Zhao X; Wu W; Gao Z; Tan X; Qian J; Chen H; Xie Y; Jin L; Han B; Lu D
Cancer Sci; 2012 Aug; 103(8):1451-9. PubMed ID: 22568453
[TBL] [Abstract][Full Text] [Related]
25. Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients.
Xu X; Ren H; Zhou B; Zhao Y; Yuan R; Ma R; Zhou H; Liu Z
Lung Cancer; 2012 Aug; 77(2):438-42. PubMed ID: 22516052
[TBL] [Abstract][Full Text] [Related]
26. Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma.
Valle CW; Min T; Bodas M; Mazur S; Begum S; Tang D; Vij N
PLoS One; 2011; 6(12):e29073. PubMed ID: 22216170
[TBL] [Abstract][Full Text] [Related]
27. The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks.
Meerang M; Ritz D; Paliwal S; Garajova Z; Bosshard M; Mailand N; Janscak P; Hübscher U; Meyer H; Ramadan K
Nat Cell Biol; 2011 Oct; 13(11):1376-82. PubMed ID: 22020440
[TBL] [Abstract][Full Text] [Related]
28. Valosin-containing protein mutation and Parkinson's disease.
Chan N; Le C; Shieh P; Mozaffar T; Khare M; Bronstein J; Kimonis V
Parkinsonism Relat Disord; 2012 Jan; 18(1):107-9. PubMed ID: 21816654
[No Abstract] [Full Text] [Related]
29. Global cancer statistics.
Jemal A; Bray F; Center MM; Ferlay J; Ward E; Forman D
CA Cancer J Clin; 2011; 61(2):69-90. PubMed ID: 21296855
[TBL] [Abstract][Full Text] [Related]
30. Exome sequencing reveals VCP mutations as a cause of familial ALS.
Johnson JO; Mandrioli J; Benatar M; Abramzon Y; Van Deerlin VM; Trojanowski JQ; Gibbs JR; Brunetti M; Gronka S; Wuu J; Ding J; McCluskey L; Martinez-Lage M; Falcone D; Hernandez DG; Arepalli S; Chong S; Schymick JC; Rothstein J; Landi F; Wang YD; Calvo A; Mora G; Sabatelli M; Monsurrò MR; Battistini S; Salvi F; Spataro R; Sola P; Borghero G; ; Galassi G; Scholz SW; Taylor JP; Restagno G; Chiò A; Traynor BJ
Neuron; 2010 Dec; 68(5):857-64. PubMed ID: 21145000
[TBL] [Abstract][Full Text] [Related]
31. Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity.
van Kuilenburg AB; Meijer J; Mul AN; Meinsma R; Schmid V; Dobritzsch D; Hennekam RC; Mannens MM; Kiechle M; Etienne-Grimaldi MC; Klümpen HJ; Maring JG; Derleyn VA; Maartense E; Milano G; Vijzelaar R; Gross E
Hum Genet; 2010 Nov; 128(5):529-38. PubMed ID: 20803296
[TBL] [Abstract][Full Text] [Related]
32. Cancer statistics, 2010.
Jemal A; Siegel R; Xu J; Ward E
CA Cancer J Clin; 2010; 60(5):277-300. PubMed ID: 20610543
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients.
Khrunin AV; Moisseev A; Gorbunova V; Limborska S
Pharmacogenomics J; 2010 Feb; 10(1):54-61. PubMed ID: 19786980
[TBL] [Abstract][Full Text] [Related]
34. Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population.
Wu W; Zhang W; Qiao R; Chen D; Wang H; Wang Y; Zhang S; Gao G; Gu A; Shen J; Qian J; Fan W; Jin L; Han B; Lu D
Clin Cancer Res; 2009 Jun; 15(11):3889-95. PubMed ID: 19458053
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia.
Djamshidian A; Schaefer J; Haubenberger D; Stogmann E; Zimprich F; Auff E; Zimprich A
Muscle Nerve; 2009 Mar; 39(3):389-91. PubMed ID: 19208399
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study.
Kim HS; Kim MK; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Gynecol Oncol; 2009 May; 113(2):264-9. PubMed ID: 19203783
[TBL] [Abstract][Full Text] [Related]
38. An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene.
Gidaro T; Modoni A; Sabatelli M; Tasca G; Broccolini A; Mirabella M
Muscle Nerve; 2008 Jan; 37(1):111-4. PubMed ID: 17763460
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel valosin-containing protein polymorphism in late-onset Alzheimer's disease.
Kaleem M; Zhao A; Hamshere M; Myers AJ
Neurodegener Dis; 2007; 4(5):376-81. PubMed ID: 17622780
[TBL] [Abstract][Full Text] [Related]
40. Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
Lauten M; Schrauder A; Kardinal C; Harbott J; Welte K; Schlegelberger B; Schrappe M; von Neuhoff N
Leukemia; 2006 May; 20(5):820-6. PubMed ID: 16541142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
